<DOC>
	<DOCNO>NCT02897063</DOCNO>
	<brief_summary>The purpose study learn effect midodrine droxidopa , two medication use treatment orthostatic hypotension ( low blood pressure stand ) , vein abdomen patient autonomic failure . The study conduct Vanderbilt University Medical Center , consist 2 part : screen 2 testing day . The total length study 5 day . About 34 participant screen study .</brief_summary>
	<brief_title>Effects Midodrine Droxidopa Splanchnic Capacitance Autonomic Failure</brief_title>
	<detailed_description>Patients multiple system atrophy , pure autonomic failure Parkinson disease , orthostatic hypotension study randomize , double-blind , 2-arm parallel design compare effect droxidopa midodrine stoke volume head tilt . A total 34 participant enrol study ( 17 patient arm ) . Screening Procedures : Potential participant screen Vanderbilt Autonomic Dysfunction Center ( ADC ) . Medications affect blood pressure , blood volume autonomic nervous system pressor medication , fludrocortisone carbidopa withdrawn least 5 half-lives study . Patients undergo complete history physical examination , ECG , routine clinical laboratory analysis blood pregnancy test woman childbearing potential . Autonomic test include tilt table test posture study plasma catecholamine perform determine meet inclusion/exclusion criterion . Eligible participant randomize droxidopa midodrine treatment group . All patient study two separate day , two day apart : one day active drug ( droxidopa 300mg PO midodrine 10mg PO ) one day placebo . On study day , two tilt table test perform . Patients instrumented measure blood pressure heart rate ( continuously intermittently ) , segmental impedance , cardiac output ( inert gas rebreathing technique and/or impedance cardiography ) , venous capacitance . Baseline measurement take supine position 30 minute , head-up tilt ≤10 minute 60 degree . Supine baseline measurement include estimation splanchnic venous capacitance . At end head tilt ( HUT ) , patient ask rate severity orthostatic symptom . Patients place seat position ( time 0 ) receive single oral dose either droxidopa 300 mg placebo , follow two hour later single oral dose placebo midodrine 10 mg. On placebo day , group receive placebo pill time 0 2 hour . After ~3 hour first drug administration , second tilt table test perform , outcome measurement repeat supine HUT . The investigator may apply abdominal compression 40 mmHg inflatable binder end second HUT . Outcome measurement repeat 5 minute compression .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Hypotension</mesh_term>
	<mesh_term>Multiple System Atrophy</mesh_term>
	<mesh_term>Shy-Drager Syndrome</mesh_term>
	<mesh_term>Pure Autonomic Failure</mesh_term>
	<mesh_term>Hypotension , Orthostatic</mesh_term>
	<mesh_term>Midodrine</mesh_term>
	<mesh_term>Droxidopa</mesh_term>
	<criteria>Male female subject , age 4080 year possible probable Multiple System Atrophy , Pure Autonomic Failure , Parkinson disease , define Consensus Criteria . Neurogenic orthostatic hypotension define ≥30mmHg decrease systolic blood pressure within 3 minute stand associate impaired autonomic reflex determine autonomic test absence identifiable cause . Subjects able willing provide inform consent . Supine hypertension , define systolic blood pressure ≥ 160 mmHg measure two separate occasion . Pregnancy . Systemic illnesses know produce autonomic neuropathy , include limited diabetes mellitus , amyloidosis , monoclonal gammopathy , autoimmune neuropathy . History know aortic aneurism , thoracic , abdominal pelvic surgery past 6 month . Symptomatic abdominal inguinal hernia . Severe gastroesophageal reflux . Recent fracture fissure rib , thoracic lumbar spine . Medical device implant abdominal wall abdomen would interfere abdominal compression . Intolerance increase intraabdominal pressure . Clinically unstable coronary artery disease major cardiovascular neurological event past 6 month , factor investigator 's opinion would prevent subject complete protocol include clinically significant abnormality clinical , mental laboratory testing .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>midodrine</keyword>
	<keyword>droxidopa</keyword>
	<keyword>splanchnic circulation</keyword>
</DOC>